Hypoxia-Targeted Drug Q6 Induces G2-M Arrest and Apoptosis via Poisoning Topoisomerase II under Hypoxia
Authors:
Open Access
- 9 December 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (12) , e0144506
Abstract
In spite of the tremendous efforts dedicated to developing hypoxia-activated prodrugs, no agents yet have been approved for clinical therapy. In the present study, the hypoxic selective anti-cancer activity as well as the cellular target of a novel tirapazamine (TPZ) analogue, 7-methyl-3-(3-chlorophenyl)-quinoxaline-2-carbonitrile 1,4-dioxide (Q6) were investigated. Q6 implemented anti-cancer effects via poisoning topoisomerase II (topo II) under hypoxia. Modified trapped in agarose DNA immunostaining (TARDIS) assay showed more topo II–DNA cleavage complexes trapped by Q6 than TPZ at even lower concentration. In addition, by introducing ataxia-telangiectasia-mutated (ATM) kinase inhibitors caffeine and KU-60019, we displayed that Q6-triggered apoptosis was attributed, at least partially, to DNA double-strand breaks generated by the topo II-targeting effect. Collectively, Q6 stood out for its better hypoxia-selectivity and topo II-poisoning than the parental compound TPZ. All these data shed light on the research of Q6 as a promising hypoxia-activated prodrug candidate for human hepatocellular carcinoma therapy.Keywords
This publication has 45 references indexed in Scilit:
- Roles of hypoxia, stem cells and epithelial–mesenchymal transition in the spread and treatment resistance of head and neck cancerJournal of Oral Pathology & Medicine, 2015
- Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinomaCancer Biology & Therapy, 2015
- Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancerCancer Biology & Therapy, 2015
- Natural Compound Alternol Induces Oxidative Stress–Dependent Apoptotic Cell Death Preferentially in Prostate Cancer CellsMolecular Cancer Therapeutics, 2014
- Simultaneous NF‐κB inhibition and E‐cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA in vitro and in vivoInternational Journal of Cancer, 2014
- Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticlesNanotoxicology, 2013
- Tirapazamine: a hypoxia-activated topoisomerase II poison.2002
- The expression of a new variant of the pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patientsHuman Molecular Genetics, 2002
- ATM and ATR: networking cellular responses to DNA damageCurrent Opinion in Genetics & Development, 2001
- AQ4N: a new approach to hypoxia-activated cancer chemotherapyBritish Journal of Cancer, 2000